Milestone Scientific Inc. (NYSE:MLSS) has a beta value of 1.27 and has seen 1,331,796 shares traded in the recent trading session. The company, currently valued at $201.01 Million, closed the recent trade at $3.03 per share which meant it gained $0.51 on the day or 20.24% during that session. The MLSS stock price is -60.07% off its 52-week high price of $4.85 and 71.95% above the 52-week low of $0.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 377.45 Million shares traded. The 3-month trading volume is 790.67 Million shares.
The consensus among analysts is that Milestone Scientific Inc. (MLSS) is an Overweight stock at the moment, with a recommendation rating of 2.5. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.02.
Milestone Scientific Inc. (NYSE:MLSS) trade information
Sporting 20.24% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, May 03 when the MLSS stock price touched $3.17-6 or saw a rise of 6.31%. Year-to-date, Milestone Scientific Inc. shares have moved 40.09%, while the 5-day performance has seen it change 14.67%. Over the past 30 days, the shares of Milestone Scientific Inc. (NYSE:MLSS) have changed -20.16%. Short interest in the company has seen 2.31 Million shares shorted with days to cover at 0.
Wall Street analysts have a consensus price target for the stock at $7, which means that the shares’ value could jump 131.02% from the levels at last check today. The projected low price target is $7 while the price target rests at a high of $7. In that case, then, we find that the latest price level in today’s session is +131.02% off the targeted high while a plunge would see the stock lose 131.02% from the levels at last check today.
Milestone Scientific Inc. (MLSS) estimates and forecasts
Figures show that Milestone Scientific Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +71.43% over the past 6 months, with this year growth rate of 0%, compared to 20.7% for the industry. Other than that, the company has, however, increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 33.3% and 66.7% for the next quarter. Revenue growth from the last financial year stood is estimated to be +62.2%.
2 analysts offering their estimates for the company have set an average revenue estimate of $2.01 Million for the current quarter. 2 have an estimated revenue figure of $2.11 Million for the next quarter concluding in June 01, 2021. Year-ago sales stood $1.3 Million and $168Million respectively for this quarter and the next, and analysts expect sales will grow by 54.6% for the current quarter and 1156% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +14.5% over the past 5 years. Earnings growth for 2021 is a modest +29.3%.
Milestone Scientific Inc. (NYSE:MLSS)’s Major holders
Insiders own 30.64% of the company shares, while shares held by institutions stand at 12.96% with a share float percentage of 18.69%. Investors are also buoyed by the number of investors in a company, with Milestone Scientific Inc. having a total of 69 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 2.55 Million shares worth more than $5.4 Million. As of December 30, 2020, Vanguard Group, Inc. (The) held 3.82% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 2.11 Million shares as of December 30, 2020. The firm’s total holdings are worth over $4.48 Million and represent 3.17% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of December 30, 2020, the former fund manager holds about 2.62% shares in the company for having 1745143 shares of worth $3.7 Million while later fund manager owns 1.09 Million shares of worth $3.88 Million as of March 30, 2021, which makes it owner of about 1.63% of company’s outstanding stock.